Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,487 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry.
Kim JK, Kim SH, Song MK, Joo J, Seo SI, Kwak C, Jeong CW, Song C, Hwang EC, Seo IY, Lee H, Hong SH, Park JY, Chung J. Kim JK, et al. Among authors: kim sh. Cancer Res Treat. 2019 Apr;51(2):758-768. doi: 10.4143/crt.2018.421. Epub 2018 Sep 7. Cancer Res Treat. 2019. PMID: 30189720 Free PMC article.
The current status of hormone treatment for prostate cancer patients in Korean real-world practice: a multi-institutional observational study.
Kim JK, Kim JJ, Gang TW, Kwon TK, Kim HS, Park SC, Park JS, Park JY, Yoon SJ, Jeon YS, Cho JS, Joo KJ, Hong SH, Byun SS; Korean Urological Oncology Society. Kim JK, et al. Among authors: kim jj, kim hs. Asian J Androl. 2019 Mar-Apr;21(2):115-120. doi: 10.4103/aja.aja_95_18. Asian J Androl. 2019. PMID: 30604695 Free PMC article.
Survival and clinical prognostic factors in metastatic non-clear cell renal cell carcinoma treated with targeted therapy: A multi-institutional, retrospective study using the Korean metastatic renal cell carcinoma registry.
Kim JK, Kim SH, Song MK, Joo J, Seo SI, Kwak C, Jeong CW, Song C, Hwang EC, Seo IY, Lee H, Hong SH, Park JY, Chung J. Kim JK, et al. Among authors: kim sh. Cancer Med. 2019 Jul;8(7):3401-3410. doi: 10.1002/cam4.2222. Epub 2019 May 9. Cancer Med. 2019. PMID: 31070307 Free PMC article.
5,487 results